Atreca Appoints Acclaimed Immunology Researcher Mark M. Davis, Ph.D., As A Technical Advisor

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today the appointment of Mark M. Davis, Ph.D., as a technical Advisor. Dr. Davis is a preeminent researcher who has greatly advanced knowledge of the human immune system during the course of his more than three-decade career at Stanford University School of Medicine.